ClostraBio

Chicago, IL · Founded 2016 · Privately Held (backing)

Developer of biopharmaceuticals intended to offer therapeutics for food allergies. ClostraBio is based in Chicago, IL and was founded in 2016. It was valued at $16 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $14.2 million across 1 recorded round; the latest was a $9.9 million early-stage round in Sep 2022.

PMV mark · valuation
$16.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$14.2M
Last round
Early Stage VC
Sep 2022
What is ClostraBio worth?
$16.0MPrivateMarketView mark · Oct 2026

Valued at $16.0M at its later-stage round, Sep 2022. Nothing has traded since.

Free account
More of ClostraBio with a free account
  • ·Watch ClostraBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

ClostraBio funding history

1 rounds
DateRoundRaisedPost-money
Sep 2022Early Stage VC$9.9M▮
Unlock post-money valuations

Membership and data by Private Market View

ClostraBio valuation

ClostraBio was valued at $16 million at its later-stage round in Sep 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has ClostraBio raised?

ClostraBio has raised $14.2 million in total; 1 of its rounds is on record. The largest on record was a $9.9 million early-stage round in Sep 2022.

ClostraBio has filed 1 Form D with the SEC, most recently in Sep 2022 ($9.9 million sold to 15 investors).

How ClostraBio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For ClostraBio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about ClostraBio

What is ClostraBio worth?
ClostraBio is valued at $16.0M as of Oct 2026. Valued at $16.0M at its later-stage round, Sep 2022. Nothing has traded since.
How much has ClostraBio raised?
ClostraBio has raised $14.2M in total funding across 1 recorded rounds.
When did ClostraBio last raise?
ClostraBio last raised in Sep 2022 (Early Stage VC), raising $9.9M.